[ad_1] Biocon Ltd is leading India’s push into weight loss drugs as patents for some of the blockbuster medications are set to expire. The pharma company has won approval from the UK regulator for the first generic version of liraglutide injectible, which is losing patent protection in November. Novo Nordisk’s weight loss drug, sold under the brand name Saxenda, is among the first anti-obesity medications to lose patent protection.…
Read More »